Moreover, inhibiting noncanonical Wnt/JNK signaling using a JNK inhibitor (SP600125) would induce canonical signaling in Ace-1-Dkk-1 and decrease tumor growth and the bone metastatic phenotype of PCa. The gene discussed is ACE; the disease is neoplasm.